Can supplemental premiums cover Medicare's growing cost of new treatments?
Core argument: The projected doubling of Medicare's cost from 3.2% to 5.4% of GDP is accounted for by increased use of healthcare services, particularly newly developed procedures and therapies not previously available.
The projected doubling of Medicare’s cost as a share of GDP is entirely accounted for by the increased use of healthcare services—particularly newly-developed procedures and therapies, which haven’t previously been available. Without this expanded provision of medical services, Medicare’s expenditures would shrink from 3.2% to 2.4% of GDP, rather than increasing to 5.4%. This is not to say that Medicare should never cover newly developed healthcare services. But which new medical technologies are developed reflects what Medicare promises to pay for. If beneficiaries want to receive additional services which increase the cost of the program, they should pay supplemental premiums to cover the expense.


